In today's first round match-up of The Motley Fool Better-Buy Tournament, Biogen squares off against Stratasys in a battle to determine which stock is the better buy now. The 64-company tournament pits two Motley Fool analysts against each other as they make the case for their stocks with the winner determined by you, the readers.
In the video below, Motley Fool analyst Max Macaluso makes the case for Biogen (BIIB -0.43%). This stock was a highflier in 2013, climbing an impressive 91%, and the stock has continued to climb higher. The company's multiple sclerosis drugs are powering its business, and its robust pipeline is also attractive for long-term investors.
Layer by layer, Stratasys (SSYS -0.10%) is establishing itself as the top-dog in 3-D printing, according to Motley Fool analyst Simon Erickson. The company now has more than 75,000 systems installed worldwide – giving it a strong recurring revenue stream from consumable materials and service contracts. Stratasys has deployed that cash to efficiently grow at all points of the market. Its MakerBot subsidiary is driving mass-market awareness, and its industrial relationships are developing new applications every year. Industrywide, 3-D printing revenue is expected to nearly quintuple during the next decade, and Stratasys is in the perfect position to benefit.
Watch these analysts square off in the video below, and then vote for a winner. Then check out the other companies in the Motley Fool Better-Buy Bracket.
This year's winning stock?
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report, "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.
Cast your vote in the poll below the video!
